The BRAF kinase domain promotes the development of gliomas in vivo.
about
A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss.
P2860
The BRAF kinase domain promotes the development of gliomas in vivo.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The BRAF kinase domain promotes the development of gliomas in vivo.
@ast
The BRAF kinase domain promotes the development of gliomas in vivo.
@en
type
label
The BRAF kinase domain promotes the development of gliomas in vivo.
@ast
The BRAF kinase domain promotes the development of gliomas in vivo.
@en
prefLabel
The BRAF kinase domain promotes the development of gliomas in vivo.
@ast
The BRAF kinase domain promotes the development of gliomas in vivo.
@en
P2093
P2860
P1433
P1476
The BRAF kinase domain promotes the development of gliomas in vivo.
@en
P2093
Allie H Grossmann
Clifford H Shin
Sheri L Holmen
P2860
P356
10.18632/GENESANDCANCER.48
P577
2015-01-01T00:00:00Z